# Evaluation for Therapeutic Plasma Exchange for Immune Mediated Neurological Disease

> **NCT07197099** · — · RECRUITING · sponsor: **Al-Azhar University** · enrollment: 60 (estimated)

## Conditions studied

- Neurological Autoimmune Diseases

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT07197099
- **Lead sponsor:** Al-Azhar University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2025-01-01
- **Primary completion:** 2025-10-30
- **Final completion:** 2025-12-31
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2025-11-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07197099

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07197099, "Evaluation for Therapeutic Plasma Exchange for Immune Mediated Neurological Disease". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT07197099. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*